Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Drug Discovery Market?

In recent times, there has been a significant increase in the size of the drug discovery market. It is projected to expand from $110.26 billion in 2024 to $125.23 billion in 2025, at a compound annual growth rate (CAGR) of 13.6%. Factors that contributed to this growth in the historic period include improvements in genomics and proteomics, an increasing incidence of chronic diseases, and the advent of biopharmaceuticals.

What Growth Rate Is Forecasted for the Drug Discovery Market by 2029?

The market size for drug discovery is predicted to experience a swift expansion in the coming years, burgeoning to $221.71 billion in 2029 with a compound annual growth rate (CAGR) of 15.3%. The projected growth in this period is credited to the adoption of precision medicine, emphasis on rare diseases, and extended personal therapies. The forecast period is expected to witness major trends such as the implementation of the collaborative drug discovery prototype, concentration on orphan drugs and rare diseases, incorporation of multi-omics data, fast-paced adoption of organoids and 3D cell culture models, and developments in virtual screening.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

Which Key Companies Are Shaping the Future of the Drug Discovery Market?

Major companies operating in the drug discovery market include Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

Which Factors Are Driving Demand in the Drug Discovery Industry?

The drug discovery market is predicted to expand as healthcare costs continue to rise. Nations globally are allocating a significant portion of their GDP to healthcare expenditures, which encompasses hospital care, physician and clinical services, other professional services, dental services, various health, residential, and personal care, home health care, nursing care facilities, continuing care retirement communities, prescription drugs, and more. Drug discovery constitutes a substantial fraction of health expenditure since it is essential for the treatment of diseases and extending life expectancy. The necessity for new medications to address emerging diseases is on the rise. For instance, the Centers for Medicare and Medicaid Services, a US federal agency, reported in October 2024 that national health expenditure increased 4.1% reaching $4.5 trillion in 2022, or $13,493 per person. Between 2023 and 2032, the average national health expenditure growth (5.6%) is expected to exceed the average GDP growth (4.3%), raising the health spending share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Hence, the growing healthcare expenditures are fueling the advancement of the drug discovery market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp

How Is the Drug Discovery Market Segmented by Several Divisions?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

What are the Emerging Market Trends Driving the Growth of the Drug Discovery Industry?

In the arena of drug discovery, technological advancements are a noteworthy trend. Numerous new technologies like AI, imaging technology, and more are being developed by firms operating in this market to decrease the time needed for discovering drugs. With the aid of imaging technology, non-invasive biological reactions to drugs within organisms can be visualized, quantified, and described. The utilization of these methods, involving probes or tissue, is critical for understanding diseases and developing new treatments. Google Cloud, for instance, in May 2023, introduced two new AI-enhanced tools, the Target and Lead Identification Suite, and the Multiomics Suite to expedite drug discovery and precision medicine. With these tools, biotech and pharmaceutical enterprises can advance their pursuits in drug discovery and precision medicine. The Target and Lead Identification Suite aids in determining the role of proteins and amino acids, while the Multiomics Suite fast tracks the discovery and interpretation of genomic data, therefore assisting in developing precisely targeted treatments.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

Which Regions Are Driving Growth in the Drug Discovery Market?

North America was the largest region in the drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7746

This Report Delivers Insight On:

1. How big is the drug discovery market, and how is it changing globally?

2. Who are the major companies in the drug discovery market, and how are they performing?

3. What are the key opportunities and risks in the drug discovery market right now?

4. Which products or customer segments are growing the most in the drug discovery market?

5. What factors are helping or slowing down the growth of the drug discovery market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model